BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Basaranoglu M, Basaranoglu G. Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis. World J Gastroenterol 2011; 17(36): 4055-4062 [PMID: 22039318 DOI: 10.3748/wjg.v17.i36.4055]
URL: https://www.wjgnet.com/1948-0210/full/v17/i36/4055.htm
Number Citing Articles
1
Metin Basaranoglu, Sonia M Najjar, Ali Ebag Demirbag, Hakan Senturk. Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting listWorld Journal of Hepatology 2016; 8(7): 376-384 doi: 10.4254/wjh.v8.i7.376
2
Taiping Li, Yanmei He, Mengli Zhang, Zhien Tan, Aihua Zhang, Min Ou, Danna Huang, Fangfang Wu, Xijun Wang. High throughput metabolomics explores the mechanism of Jigucao capsules in treating Yanghuang syndrome rats using ultra-performance liquid chromatography quadrupole time of flight coupled with mass spectrometryJournal of Chromatography B 2022; 1194: 123185 doi: 10.1016/j.jchromb.2022.123185
3
Roaid Khan, Graham R. Foster, Tahseen A. Chowdhury. Managing Diabetes in Patients with Chronic Liver DiseasePostgraduate Medicine 2012; 124(4): 130 doi: 10.3810/pgm.2012.07.2574
4
Metin Basaranoglu, Billur Canbakan, Kemal Yildiz, Bahadir Ceylan, Birol Baysal, Omer Uysal, Hakan Senturk. Nonalcoholic fatty liver may increase the risk of operation in patients with fatty liver and the frequency of cancer in their first-degree relativesWiener klinische Wochenschrift 2016; 128(19-20): 691 doi: 10.1007/s00508-015-0744-4
5
Yu-Min Lin, Hung-Yu Sun, Wen-Tai Chiu, Hui-Chen Su, Yu-Chieh Chien, Heng-Ai Chang, Lee-Won Chong, Hung-Chuen Chang, Kung-Chia Young, Chyi-Huey Bai, Chiung-Wen Tsao. Etifoxine, a TSPO Ligand, Worsens Hepatitis C-Related Insulin Resistance but Relieves Lipid AccumulationBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/3102414
6
Annalisa Cespiati, Inês Coelho Rodrigues, Inês Santos, Sara Policarpo, Sofia Carvalhana, Anna Ludovica Fracanzani, Helena Cortez‐Pinto. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic reviewLiver International 2024; 44(5): 1075 doi: 10.1111/liv.15876
7
Luis A. Salazar, Xóchitl García-Samper, Susana Alcázar-Leyva, Patricia Gorocica, Eduarda Cerón, María Cristina Negrete-García, Luis F. Montaño, Noé Alvarado-Vásquez. Levels of TNF-<i>α</i>, IL-1<i>β</i>, TGF-<i>β</i>, and IL-6 in patients with chronic hepatitis C virus infection and hyperinsulinemiaOpen Journal of Immunology 2013; 3(01): 17 doi: 10.4236/oji.2013.31003
8
Vahdat Poortahmasebi, Seyed Moayed Alavian, Hossein Keyvani, Mehdi Norouzi, Mahmood Mahmoodi, Seyed Mohammad Jazayeri. Hepatic Steatosis: Prevalence and Host/Viral Risk Factors in Iranian Patients with Chronic Hepatitis B InfectionAsian Pacific Journal of Cancer Prevention 2014; 15(9): 3879 doi: 10.7314/APJCP.2014.15.9.3879
9
Xiang-Li Bai, Xiu-Ling Deng, Guang-Jie Wu, Wen-Jing Li, Si Jin. Rhodiola and salidroside in the treatment of metabolic disordersMini-Reviews in Medicinal Chemistry 2019; 19(19): 1611 doi: 10.2174/1389557519666190903115424
10
Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina. The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysisActa Diabetologica 2019; 56(3): 341 doi: 10.1007/s00592-018-1257-1
11
Lokesh P. Tripathi, Hiroto Kambara, Yi-An Chen, Yorihiro Nishimura, Kohji Moriishi, Toru Okamoto, Eiji Morita, Takayuki Abe, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Understanding the Biological Context of NS5A–Host Interactions in HCV Infection: A Network-Based ApproachJournal of Proteome Research 2013; 12(6): 2537 doi: 10.1021/pr3011217
12
S.-Y. Lin, C.-L. Lin, C.-H. Tseng, I.-K. Wang, S.-M. Wang, C.-C. Huang, Y.-J. Chang, C.-H. Kao. The association between chronic osteomyelitis and increased risk of diabetes mellitus: a population-based cohort studyEuropean Journal of Clinical Microbiology & Infectious Diseases 2014; 33(9): 1647 doi: 10.1007/s10096-014-2126-7
13
Takashi Oono, Takahiro Yamasaki, Junichi Zaitsu, Issei Saeki, Takuya Iwamoto, Yumiko Harima, Yoshio Marumoto, Isao Hidaka, Yohei Urata, Tsuyoshi Ishikawa, Taro Takami, Makoto Segawa, Koichi Uchida, Shuji Terai, Ichiro Kunitugu, Tsuyoshi Tanabe, Isao Sakaida. Association of tyrosine with insulin resistance in hepatitis C virus‐related chronic liver diseaseHepatology Research 2014; 44(10) doi: 10.1111/hepr.12213
14
Yuki Haga, Tatsuo Kanda, Reina Sasaki, Masato Nakamura, Shingo Nakamoto, Osamu Yokosuka. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosisWorld Journal of Gastroenterology 2015; 21(46): 12989-12995 doi: 10.3748/wjg.v21.i46.12989
15
Shira Yair-Sabag, Elchanan Nussinson, Ofir Ben-Assuli, Fahmi Shibli, Azmi Shahbari, Shira Zelber-Sagi. Retrospective study of the associations between hepatitis C virus infection and metabolic factorsWorld Journal of Hepatology 2016; 8(30): 1269-1278 doi: 10.4254/wjh.v8.i30.1269
16
Metin Basaranoglu. Increased prevalence of portal vein thrombosis in patients with nonalcoholic steatohepatitis-cirrhosis due to increased proinflammatory cytokines releasing from abdominal adipose tissueEuropean Journal of Gastroenterology & Hepatology 2020; 32(3): 458 doi: 10.1097/MEG.0000000000001564
17
Alaaeldin Abdelsalam Dawood, Mohamed Zakarya Nooh, Ayman Abdelhaleem Elgamal. Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4Diabetes & Metabolism Journal 2017; 41(4): 316 doi: 10.4093/dmj.2017.41.4.316
18
Gaurav V. Sarode, Kari Neier, Noreene M. Shibata, Yuanjun Shen, Dmitry A. Goncharov, Elena A. Goncharova, Tagreed A. Mazi, Nikhil Joshi, Matthew L. Settles, Janine M. LaSalle, Valentina Medici. Wilson Disease: Intersecting DNA Methylation and Histone Acetylation Regulation of Gene Expression in a Mouse Model of Hepatic Copper AccumulationCellular and Molecular Gastroenterology and Hepatology 2021; 12(4): 1457 doi: 10.1016/j.jcmgh.2021.05.020
19
Busara Songtanin, Kenneth Nugent. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus InfectionBiology 2022; 12(1): 23 doi: 10.3390/biology12010023
20
Laure Perrin-Cocon, Olivier Diaz, Patrice André, Vincent Lotteau. Modified lipoproteins provide lipids that modulate dendritic cell immune functionBiochimie 2013; 95(1): 103 doi: 10.1016/j.biochi.2012.08.006
21
Mahmoud Khattab, Mohamed Amin Sakr, Mohamed Abdel Fattah, Youssef Mousa, Elwy Soliman, Ashraf Breedy, Mona Fathi, Salwa Gaber, Ahmed Altaweil, Ashraf Osman, Ahmed Hassouna, Ibrahim Motawea. Novel non-invasive biological predictive index for liver fibrosis in hepatitis C virus genotype 4 patientsWorld Journal of Hepatology 2016; 8(32): 1392-1401 doi: 10.4254/wjh.v8.i32.1392
22
Tumusime Musafiri, Innocent Kamali, Casmille Kayihura, Jean de la Paix Gakuru, Francoise Nyirahabihirwe, Esdras Nizeyimana, Pilar Kandamage, Placide Habinshuti, Raymond Sekagarura, Jean Damascene Makuza, Nadine Karema, Janvier Serumondo, Theoneste Ntakirutimana, Jean d’Amour Ndahimana, Dale A. Barnhart. Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional studyBMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-023-08678-y